Experience of using subcutaneous levetiracetam in palliative patients

Neurologia (Engl Ed). 2021 Jul-Aug;36(6):474-475. doi: 10.1016/j.nrleng.2020.06.012. Epub 2021 Apr 17.

Authors

G Más-Sesé¹, D Martín-Bautista², A Navarro-Catalá³

Affiliations

¹ Unidad de Neurología, Hospital la Pedrera, Denia, Alicante, Spain. Electronic address: gemmasese@gmail.com.
² Unidad de Neurología, Hospital la Pedrera, Denia, Alicante, Spain.
³ Farmacia Hospitalaria, Hospital la Pedrera, Denia, Alicante, Spain.

PMID: 34238530
DOI: 10.1016/j.nrleng.2020.06.012

No abstract available

Publication types

Letter

MeSH terms

Humans
Levetiracetam* / therapeutic use
Palliative Care*
Piracetam

Substances

Levetiracetam
Piracetam